Search
for
Sort by
Research 751–780 of 1000+
- A clinical investigation of early‐onset alopecia areata in children: Onset earlier than 4 years of age might have a better short‐term prognosis
- An investigation of vitamin D status in alopecia areata
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
- Treatment of alopecia universalis with oral alitretinoin: A case report
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Assessment of vitamin D levels in patients with alopecia areata: a case-control study in a Tertiary Care Hospital in North India
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- A Comparative Study of the Therapeutic Effects of Intralesional Triamcinolone Acetonide and Platelet-Rich Plasma in Alopecia Areata at a Tertiary Health-Care Centre
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Granulomatous Alopecia Areata: A Rare Report With a Review
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Autoimmune associations of alopecia areata in pediatric population - A study in tertiary care centre
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- A prospective study on the efficacy of platelet rich plasma in alopecia areata
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- rs4541843 G > A variant near miR-182 is associated with susceptibility, severity, and increased hsa-miR-182-5p expression in alopecia areata
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- Baricitinib regrows hair in adolescents with alopecia areata
- Comparative efficacy of topical calcipotriol and tacrolimus in alopecia areata: A prospective trial
- Efficacy of Topical Clobetasol Propionate 0.05% Ointment and Topical Tacrolimus 0.1% Ointment in Treatment of Alopecia Areata.: RCT
- Study of vitamin D deficiency in patients with alopecia areata attending a dermatology center in Iran